SPEEDA
SPEEDA
SPEEDA
1. Identification
Product identifier RABIPUR RABIES VACCINE
Other means of identification
Synonyms RABAVERT VACCINE, SUSPENSION FOR INJECTION (US) * RABIPUR (LYOPHILISATE),
RABIES VACCINE, SUSPENSION FOR INJECTION (EU) * RABAVERT RABIES VACCINE *
PURIFIED CHICK EMBRYO CELL VACCINE (PCECV)
Recommended use Medicinal Product.
This safety data sheet is written to provide health, safety and environmental information for people
handling this formulated product in the workplace. It is not intended to provide information relevant
to medicinal use of the product. In this instance patients should consult prescribing
information/package insert/product label or consult their pharmacist or physician. For health and
safety information for individual ingredients used during manufacturing, refer to the appropriate
safety data sheet for each ingredient.
Recommended restrictions No other uses are advised.
Manufacturer/Importer/Supplier/Distributor information
Manufacturer
GlaxoSmithKline US
5 Moore Drive
Research Triangle Park, NC 27709 USA
US General Information (normal business hours): +1-888-825-5249
2. Hazard(s) identification
Classified hazards
Exempt from requirements - product regulated as a medicinal product, cosmetic product or medical device.
Label elements
Exempt from requirements - product regulated as a medicinal product, cosmetic product or medical device.
Hazard(s) not otherwise classified (HNOC)
Exempt from requirements - product regulated as a medicinal product, cosmetic product or medical device.
3. Composition/information on ingredients
Mixtures
Chemical name Common name and synonyms CAS number %
INACTIVATED RABIES VIRUS Unassigned < 75
4. First-aid measures
Inhalation Move to fresh air. If breathing is difficult, trained personnel should give oxygen. Call a physician if
symptoms develop or persist. Under normal conditions of intended use, this material is not
expected to be an inhalation hazard.
Skin contact Immediately flush skin with plenty of water. Take off contaminated clothing and wash before reuse.
Get medical attention if symptoms occur.
Eye contact Rinse thoroughly with plenty of water for at least 15 minutes and consult a physician.
Ingestion If swallowed, rinse mouth with water (only if the person is conscious). If ingestion of a large
amount does occur, call a poison control center immediately. Do not induce vomiting without
advice from poison control center.
Most important None known.
symptoms/effects, acute and
delayed
Indication of immediate No specific antidotes are recommended. Treat according to locally accepted protocols. For
medical attention and special additional guidance, refer to the current prescribing information or to the local poison control
treatment needed information center.
General information In the case of accident or if you feel unwell, seek medical advice immediately (show the label
where possible). Ensure that medical personnel are aware of the material(s) involved, and take
precautions to protect themselves.
5. Fire-fighting measures
Suitable extinguishing media Alcohol resistant foam. Water. Foam. Dry chemical powder. Carbon dioxide (CO2).
Unsuitable extinguishing None known.
media
Specific hazards arising from During fire, gases hazardous to health may be formed.
the chemical
Special protective equipment Self-contained breathing apparatus and full protective clothing must be worn in case of fire.
and precautions for firefighters
Fire fighting Move containers from fire area if you can do so without risk.
equipment/instructions
Specific methods Use standard firefighting procedures and consider the hazards of other involved materials.
Skin protection
Hand protection Not normally needed. For prolonged or repeated skin contact use suitable protective gloves.
Other Not normally needed. Wear suitable protective clothing as protection against splashing or
contamination.
Respiratory protection No personal respiratory protective equipment normally required. Use a NIOSH/MSHA approved
respirator if there is a risk of exposure to dust/fume at levels exceeding the exposure limits.
Thermal hazards Wear appropriate thermal protective clothing, when necessary.
General hygiene Always observe good personal hygiene measures, such as washing after handling the material
considerations and before eating, drinking, and/or smoking. Routinely wash work clothing and protective
equipment to remove contaminants. For advice on suitable monitoring methods, seek guidance
from a qualified environment, health and safety professional.
* Estimates for product may be based on additional component data not shown.
Skin corrosion/irritation Health injuries are not known or expected under normal use.
Corrosivity
NEOMYCIN SULFATE Literature search
Result: Irritant
Serious eye damage/eye Health injuries are not known or expected under normal use.
irritation
Eye
NEOMYCIN SULFATE Literature search
Result: Irritant
Respiratory or skin sensitization
Respiratory sensitization Not established.
NEOMYCIN SULFATE Literature search
Result: Positive
Skin sensitization This product is not expected to cause skin sensitization.
Sensitization
NEOMYCIN SULFATE Literature search
Result: Positive
Germ cell mutagenicity No data available to indicate product or any components present at greater than 0.1% are
mutagenic or genotoxic.
Carcinogenicity Not classifiable as to carcinogenicity to humans.
NEOMYCIN SULFATE 25 mg/kg/day, Auditory toxicity, no evidence of carcinogenicity.
Species: Rat
Observation Period: 104 weeks
IARC Monographs. Overall Evaluation of Carcinogenicity
Not available.
OSHA Specifically Regulated Substances (29 CFR 1910.1001-1050)
Not listed.
US. National Toxicology Program (NTP) Report on Carcinogens
Not available.
Reproductive toxicity Components in this product have been shown to cause birth defects and reproductive disorders in
laboratory animals. These effects are linked only to high doses of this substance; low doses did
not produce this adverse effect.
Reproductivity
NEOMYCIN SULFATE 100 mg/kg/day Embryo-foetal development, Intra-muscular
administration.
Result: Auditory toxicity in offspring.
Species: Rat
Notes: Shepherd's Catalogue of Teratogenic Agents.
25 mg/kg/day 3-generation study, Dietary study.
Result: NOAEL (maximum dose)
Species: Rat
Notes: WHO Food Additive Series
25 mg/kg/day, Dietary study.
Result: No adverse foetal effects observed.
Species: Rat
Notes: WHO Food Additive Series
4 g/l Embryo-foetal development, Administered in drinking
water.
Result: No malformations.
Species: Mouse
Notes: Shepherd's Catalogue of Teratogenic Agents.
* Estimates for product may be based on additional component data not shown.
Persistence and degradability
Biodegradability
Percent degradation (Aerobic biodegradation-inherent)
ETHYLENEDIAMINETETRAACETIC ACID, DISODIUM 37 %, 14 days Zahn-Wellens, Activated sludge
SALT, DIHYDRATE
Percent degradation (Aerobic biodegradation-ready)
ETHYLENEDIAMINETETRAACETIC ACID, DISODIUM 28 %, 28 days Sturm test
SALT, DIHYDRATE
Percent degradation (Aerobic biodegradation-soil)
ETHYLENEDIAMINETETRAACETIC ACID, DISODIUM 13 - 45 %, 15 weeks
SALT, DIHYDRATE
Bioaccumulative potential
Bioconcentration factor (BCF)
ETHYLENEDIAMINETETRAACETIC ACID, DISODIUM 0.8 - 1.8 Measured, Lepomis macrochirus, bluegill sunfish
SALT, DIHYDRATE
Mobility in soil Not available.
Mobility in general Not available.
Other adverse effects Not available.